- Home
- MIRM vs MDA Comparison
MIRM vs MDA Comparison
Compare MIRM & MDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIRM | MDA |
|---|---|---|
| Founded | 2018 | 1969 |
| Country | United States | Canada |
| Employees | N/A | 4000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Electronic Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 4.8B |
| IPO Year | 2019 | 2026 |
Fundamental Metrics
Financial Performance| Metric | MIRM | MDA |
|---|---|---|
| Price | $106.24 | $37.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 2 |
| Target Price | ★ $119.85 | $37.50 |
| AVG Volume (30 Days) | ★ 667.9K | 577.9K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.59 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $19,138,000.00 | N/A |
| Revenue This Year | $26.22 | $12.11 |
| Revenue Next Year | $22.04 | $11.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $42.89 | $23.23 |
| 52 Week High | $112.00 | $37.62 |
Technical Indicators
Market Signals| Indicator | MIRM | MDA |
|---|---|---|
| Relative Strength Index (RSI) | 62.25 | 66.45 |
| Support Level | $87.26 | $28.96 |
| Resistance Level | $107.51 | $37.45 |
| Average True Range (ATR) | 5.87 | 1.94 |
| MACD | 0.98 | 0.56 |
| Stochastic Oscillator | 75.13 | 96.65 |
Price Performance
Historical ComparisonAbout MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
About MDA MDA Space Ltd. Common Shares
MDA Space Ltd is a developer and manufacturer of technology and services to the space industry. It is an international space mission partner and robotics, satellite systems, and geo-intelligence pioneer. It is engaged in communications satellites, Earth and space observation, space exploration, and infrastructure. The Company collaborates and partners with governments and space agencies, commercial space companies, and defence and aerospace prime contractors in the space industry. Geographically, it generates the majority of its revenue from Canada.